Jonae Barnes | executive |
Jean-Pierre Sommadossi | executive |
Janet Hammond | executive |
John Vavricka | executive |
Andrea Corcoran | executive |
Eric Joseph | analyst |
Maxwell Skor | analyst |
Jessica Hanitta Hui | analyst |
Rosa Chen | analyst |
Good afternoon, everyone, and welcome to the Atea Pharmaceuticals Fourth Quarter 2023 Financial Results and Business Update Conference Call. [Operator Instructions] I would now like to turn the call over to Jonae Barnes, Senior Vice President of Investor Relations and Corporate Communications at Atea Pharmaceuticals. Ms. Barnes, please proceed.
Good afternoon, everyone, and welcome to Atea Pharmaceuticals Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call.